Titus H. Harris Chair, Harry K. Davis Professor, Professor and Chairperson, Department of Psychiatry, The University of Texas Medical Branch, Galveston, TX, USA.
J Affect Disord. 2014 Dec;169 Suppl 1:S12-6. doi: 10.1016/S0165-0327(14)70004-7.
Patients with bipolar disorder spend approximately half of their lives symptomatic and the majority of that time suffering from symptoms of depression, which complicates the accurate diagnosis of bipolar disorder.
Challenges in the differential diagnosis of bipolar disorder and major depressive disorder are reviewed, and the clinical utility of several screening instruments is evaluated.
The estimated lifetime prevalence of major depressive disorder (i.e., unipolar depression) is over 3 and one-half times that of bipolar spectrum disorders. The clinical presentation of a major depressive episode in a bipolar disorder patient does not differ substantially from that of a patient with major depressive disorder (unipolar depression). Therefore, it is not surprising that without proper screening and comprehensive evaluation many patients with bipolar disorder may be misdiagnosed with major depressive disorder (unipolar depression). In general, antidepressants have demonstrated little or no efficacy for depressive episodes associated with bipolar disorder, and treatment guidelines recommend using antidepressants only as an adjunct to mood stabilizers for patients with bipolar disorder. Thus, correct identification of bipolar disorder among patients who present with depression is critical for providing appropriate treatment and improving patient outcomes.
Clinical characteristics indicative of bipolar disorder versus major depressive disorder identified in this review are based on group differences and may not apply to each individual patient.
The overview of demographic and clinical characteristics provided by this review may help medical professionals distinguish between major depressive disorder and bipolar disorder. Several validated, easily administered screening instruments are available and can greatly improve the recognition of bipolar disorder in patients with depression.
双相情感障碍患者大约有一半的时间会出现症状,而且大部分时间都会出现抑郁症状,这使得双相情感障碍的准确诊断变得复杂。
回顾了双相情感障碍和重性抑郁障碍的鉴别诊断挑战,并评估了几种筛查工具的临床实用性。
重性抑郁障碍(即单相抑郁)的终身患病率估计超过双相谱系障碍的三倍半。在双相情感障碍患者中,重性抑郁发作的临床表现与重性抑郁障碍(单相抑郁)患者的临床表现并无显著差异。因此,在没有适当的筛查和全面评估的情况下,许多双相情感障碍患者可能被误诊为重性抑郁障碍(单相抑郁),这并不奇怪。一般来说,抗抑郁药对与双相情感障碍相关的抑郁发作几乎没有或没有疗效,治疗指南建议仅将抗抑郁药作为双相情感障碍患者的情绪稳定剂的辅助治疗。因此,正确识别出现抑郁症状的双相情感障碍患者对于提供适当的治疗和改善患者预后至关重要。
本综述中确定的提示双相情感障碍与重性抑郁障碍的临床特征是基于组间差异,可能不适用于每个个体患者。
本综述提供的人口统计学和临床特征概述可能有助于医疗专业人员区分重性抑郁障碍和双相情感障碍。有几种经过验证、易于管理的筛查工具可供使用,可以大大提高对抑郁患者中双相情感障碍的识别。